Les conférences de l'IUFRS · Cancer Symptom Science State-of-the-art
A panel of experts in cancer symptom science from different institutions in the United States will share their experience and recommendations for setting up a symptom science nursing research program.
Cancer Symptom Science State-of-the-art: What is Symptom Science, why is it crucial for nursing research, and how can we use its findings in clinical practice?
Talks & Panel discussion
A panel of experts from different US universities will share completed as well as ongoing research projects in the rapidly growing field of symptom science in oncology.
Following three short talks by Prof. Miaskowski, Dr. Pozzar, and Prof. Cooley, all experts will engage in a panel discussion, moderated by Dr. Sara Colomer-Lahiguera, which will address questions as to which resources and frameworks are needed to successfully implement symptom science nursing research programs in Switzerland.
1) "What?" - State of the Art in Symptom and Nursing Science (C. Miaskowski)
The first talk will “set the stage” by providing an historical perspective on symptom science research. The presentation will describe landmark achievements in symptom science research. In addition, it will discuss significant gaps in knowledge, potential pitfalls to moving the science forward, and critical directions to make advances in symptom research to improve the care of patients with unrelieved symptoms.
2) "Why?" - Unlocking the Potential of Symptom Science in the Era of Precision Health (R. Pozzar)
In a growing number of health care contexts, electronic symptom reports are collected as part of routine care. Researchers have identified symptom clusters in a variety of health conditions, yet electronic symptom reports focus on the assessment and management of individual symptoms. Likewise, the potential for patient-reported data to identify patients at increased risk for adverse symptom experiences has not been realized. In this talk, Dr. Pozzar will describe the potential for symptom science to inform innovations in health informatics that advance precision health.
3) "How?" - Integration of Different Data Sources for Clinical Decision Support Algorithms (M. Cooley)
This presentation will discuss the need for clinical decision support to improve symptom management during treatment for cancer, provide an overview of a clinical decision support system and the types of information needed to inform the delivery of patient-specific recommendations that can be delivered at the point-of-care. The challenges and lessons learned in the development of this system will be highlighted.
The talks and panel discussion will be held in English and will also be livestreamed.
When? October 12, 2023 | 17h
Where? CHUV Bâtiment hospitalier (BH08) - Auditoire Mathias Mayor & online (WEBEX link)
Language? English
Christine Miaskowski is a Professor the Department of Physiological Nursing and Sharon A. Lamb Endowed Chair in Symptom Management Research in the School of Nursing at the University of California in San Francisco. She is the first nurse to be awarded an American Cancer Society Clinical Research Professorship. Dr. Miaskowski received her Bachelor’s Degree in Nursing from Molloy College in New York, her Master’s degree in Nursing from Adelphi University, as well as a Master’s degree in Biology and a PhD in Physiology from St. John’s University in New York. After completing her doctoral degree, she completed a postdoctoral fellowship as a Robert Wood Johnson Clinical Nurse Scholar. Dr. Miaskowski’s program of research focuses on the identification of demographic, clinical, and behavioral characteristics as well as molecular markers that place patients at highest risk for the development of the most deleterious symptoms that occur as a result of cancer and its treatment. The author of over 700 peer-reviewed publications and four books, she has received numerous honors and awards, including the Distinguished Researcher Award from the Oncology Nursing Society, the Distinguished Merit Award from the International Society of Nurses in Cancer Care, as well as the Distinguished Service Award from the Oncology Nursing Society and the American Pain Society.
Rachel Pozzar is a Nurse Scientist in the Phyllis F. Cantor Center for Research in Nursing and Patient Care Services at Dana-Farber Cancer Institute and an Instructor of Medicine at Harvard Medical School. Dr. Pozzar received her PhD from Northeastern University, her MSN from Boston College, and her BSN from the University of Massachusetts, Boston. Her research is focused on digital health interventions; symptom science; patient-clinician communication; and treatment decision making among individuals with advanced cancers. Her current projects aim to pilot test her Collaborative Agenda-Setting Intervention (CASI), a tool that is embedded into the electronic health record, as well as to identify optimal strategies by which to engage racially and ethnically diverse patients and clinicians in a digital health tool for remote symptom monitoring. In 2023, Dr Pozzar received the Oncology Nursing Society’s Victoria Mock New Investigator Award.
Mary E. Cooley is a nurse scientist at Dana-Farber Cancer Institute in Boston. She completed her doctoral and post-doctoral studies at the University of Pennsylvania. Her program of research focuses on improving cancer symptom management through clinical decision support and enhancing healthy behaviors through multiple risk reduction interventions. She is collaborating with Elimu Informatics on a project focused on enabling clinical decision support for cancer symptom management that is funded as a Small Business Innovation Research contract through the National Cancer Institute. She has served on a number of scientific review committees and is currently the Chair-person for the Cancer Care Delivery Research Committee for NRG Oncology and a member of the National Cancer Institute Cancer Care Delivery Steering Committee.
Susan K. Wesmiller is an Associate Professor and Vice Chair of Research at the University of Pittsburgh School of Nursing. She completed her BSN, MSN, and PhD at the University of Pittsburgh School of Nursing, where she further performed her post-doctoral studies in Cancer Survivorship. Dr. Wesmiller's nursing career has spanned over forty years in research, education and service. Her program of research has focused on symptom science, specifically on the prediction, prevention and management of severe treatment-induced nausea and vomiting and co-occurring symptoms in women with breast cancer. Prior to moving to academia, Dr. Wesmiller was the Director of Nursing Education and Research at the University of Pittsburgh Medical Center. She currently teaches genetics in the school of nursing, and is active in the International Society of Nurse’s in Genetics (ISONG), currently serving as Past-President.
Marilyn J. Hammer is an Adjunct Associate Professor at New York University (NYU) Meyers College of Nursing and Icahn School of Medicine at Mount Sinai, and the current Director of The Phyllis F. Cantor Center for Research in Nursing and Patient Care Services at Dana-Farber Cancer Institute (Boston). She is also a member of faculty at Harvard Medical School and a fellow of The Royal Academy of Medicine. Dr. Hammer received her PhD and MN from the University of Washington, Seattle, and her BSN from the University of Texas at Arlington. Her program of research focuses on precision health symptom science, with a special interest in investigating symptom experiences, biomarkers, and wearable data to capture symptom and quality of life experiences in cancer patients. Dr. Hammer is the recipient of multiple awards, and a member of various prestigious associations, including the American Academy of Nursing, the New York Academy of Sciences and the New York Academy of Medicine.
Carolyn S. Harris is a postdoctoral scholar in the Targeted Research and Academic Training of Nurses in Genomics program at the University of Pittsburgh School of Nursing, in Pittsburgh, Pennsylvania. Her research is centered on an investigation of the social, environmental, and molecular factors that underlie symptom clusters and contribute to health disparities in patients receiving cancer treatment.
_________________________________________________
About "Les conférences de l'IUFRS"
The IUFRS conferences are a seminar series centered on topics of research and practice in nursing and healthcare.
- Target audience: Healthcare researchers and clinicians, graduate and PhD students in the nursing and healthcare sciences
- Format: Hybrid (in-person & online)
- Duration: Expert talk (40 min), followed by a Q&A (15 min)
- Language: French, English or bilingually (depending on the speaker)
En savoir plus sur "Les conférences de l'IUFRS"
Les conférences de l'IUFRS sont une série de seminaires centrés sur des sujets de recherche et de pratique en sciences infirmières et sciences de la santé.
- Public cible: Chercheur·euses et clinicien·nes, étudiant·es Master et doctorant·es en sciences infirmières et sciences de la santé
- Format: Hybride (en présentiel & en ligne)
- Durée: Présentation par un·e expert·e (40 min), suivi par Q/R(15 min)
- Langue: Français, anglais ou bilïngue (selon expert·e invité·e)
Plus d'informations: Les conférences de l'IUFRS